nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive study to protein retention in hydrophobic interaction chromatography
|
Baca, Martyna |
|
2016 |
1032 |
C |
p. 182-188 7 p. |
artikel |
2 |
Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species
|
Sarrut, Morgan |
|
2016 |
1032 |
C |
p. 91-102 12 p. |
artikel |
3 |
Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I − Optimization of separation conditions
|
Sarrut, Morgan |
|
2016 |
1032 |
C |
p. 103-111 9 p. |
artikel |
4 |
A new anti-human Fc method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in serum from pre-clinical species
|
Excoffier, Mélissa |
|
2016 |
1032 |
C |
p. 149-154 6 p. |
artikel |
5 |
Antibody-drug conjugate characterization by chromatographic and electrophoretic techniques
|
Chen, Tao |
|
2016 |
1032 |
C |
p. 39-50 12 p. |
artikel |
6 |
A simple LC/MRM–MS-based method to quantify free linker-payload in antibody-drug conjugate preparations
|
Zmolek, Wesley |
|
2016 |
1032 |
C |
p. 144-148 5 p. |
artikel |
7 |
Assessing analytical comparability of biosimilars: GCSF as a case study
|
Nupur, Neh |
|
2016 |
1032 |
C |
p. 165-171 7 p. |
artikel |
8 |
Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms
|
Hickey, John M. |
|
2016 |
1032 |
C |
p. 23-38 16 p. |
artikel |
9 |
Challenges in liquid chromatographic characterization of proteins
|
Bobály, Balázs |
|
2016 |
1032 |
C |
p. 3-22 20 p. |
artikel |
10 |
Characterization and comparability of stress-induced oxidation and deamidation on vulnerable sites of etanercept products
|
Huang, Li-Juan |
|
2016 |
1032 |
C |
p. 189-197 9 p. |
artikel |
11 |
Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP
|
Lancaster, Catherine |
|
2016 |
1032 |
C |
p. 218-223 6 p. |
artikel |
12 |
Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection
|
Stoll, Dwight |
|
2016 |
1032 |
C |
p. 51-60 10 p. |
artikel |
13 |
Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products
|
Gahoual, Rabah |
|
2016 |
1032 |
C |
p. 61-78 18 p. |
artikel |
14 |
Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies
|
Suárez, Inmaculada |
|
2016 |
1032 |
C |
p. 155-164 10 p. |
artikel |
15 |
Development of a rapid RP-UHPLC–MS method for analysis of modifications in therapeutic monoclonal antibodies
|
Zhang, Bing |
|
2016 |
1032 |
C |
p. 172-181 10 p. |
artikel |
16 |
Editorial Board
|
|
|
2016 |
1032 |
C |
p. i- 1 p. |
artikel |
17 |
Editorial for the special issue entitled “Biopharmaceuticals 2016”
|
Fekete, Szabolcs |
|
2016 |
1032 |
C |
p. 1-2 2 p. |
artikel |
18 |
Immunoaffinity extraction using conformation-dependent antibodies coupled to SE-HPLC for the development of stability and potency-indicating assay for quadrivalent human papillomavirus vaccine
|
Mostafa, Moushira M. |
|
2016 |
1032 |
C |
p. 211-217 7 p. |
artikel |
19 |
Importance of vial shape and type on the reproducibility of size exclusion chromatography measurement of monoclonal antibodies
|
Rodriguez-Aller, Marta |
|
2016 |
1032 |
C |
p. 131-138 8 p. |
artikel |
20 |
Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization
|
Terral, Guillaume |
|
2016 |
1032 |
C |
p. 79-90 12 p. |
artikel |
21 |
Investigation of low recovery in the free drug assay for antibody drug conjugates by size exclusion—reversed phase two dimensional-liquid chromatography
|
Li, Yi |
|
2016 |
1032 |
C |
p. 112-118 7 p. |
artikel |
22 |
Method development and qualification of capillary zone electrophoresis for investigation of therapeutic monoclonal antibody quality
|
Suba, Dávid |
|
2016 |
1032 |
C |
p. 224-229 6 p. |
artikel |
23 |
Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansine
|
Sandra, Koen |
|
2016 |
1032 |
C |
p. 119-130 12 p. |
artikel |
24 |
Parallel development of chromatographic and mass-spectrometric methods for quantitative analysis of glycation on an IgG1 monoclonal antibody
|
Viski, Kornél |
|
2016 |
1032 |
C |
p. 198-204 7 p. |
artikel |
25 |
Quantitative antibody-free LC–MS/MS analysis of sTRAIL in sputum and saliva at the sub-ng/mL level
|
Wilffert, Daniel |
|
2016 |
1032 |
C |
p. 205-210 6 p. |
artikel |
26 |
Rapid N-glycan release from glycoproteins using immobilized PNGase F microcolumns
|
Szigeti, Marton |
|
2016 |
1032 |
C |
p. 139-143 5 p. |
artikel |